Li et al. detected lower expression of METTL3 in renal cell carcinoma (RCC) tissues compared with adjacent non-tumor tissues and also showed that higher expression of METTL3 might predict better survival outcome of RCC patients, possibly by promoting cell cycle arrest in G1 phase and thus suppressing tumor growth [115]. Here, METTL3 is linked to renal cell carcinoma.